The second set of prizes given at our dinner in NYC on Friday evening, July 29, went to three more promising young scientists receiving the Brain & Behavior Research Foundation Freedman Prizes. The Freedman Prize...
- Mental Illnesses
- Finding Answers
- Recovery Stories
- NARSAD Grants & Prizes
- Apply for a NARSAD Grant
- Our Scientific Council
- NARSAD Young Investigator Grant
- NARSAD Independent Investigator Grants
- NARSAD Distinguished Investigator Grant
- Klerman & Freedman Prizes
- Outstanding Achievement Prizes
- Productive Lives Awards
- Productive Lives Nomination Form
- Frequently Asked Questions (FAQs)
- Get Involved
Did you know that schizophrenia affects more than 1 percent of the world's population? See NARSAD Grants at work on the latest schizophrenia research
Schizophrenia is a severe, chronic, and generally disabling brain and behavior disorder. It is most accurately described as a psychosis - a type of illness that causes severe mental disturbances that disrupt normal thoughts, speech, and behavior. Schizophrenia is believed to be caused by a combination of genetic and environmental factors.
Positive symptoms may include delusions, thought disorders, and hallucinations. People with schizophrenia may hear voices other people don't hear, or believe other people are reading their minds, controlling their thoughts, or plotting to harm them. Negative symptoms may include avolition (a lack of desire or motivation to accomplish goals), lack of desire to form social relationships, and blunted affect and emotion. Cognitive symptoms involve problems with attention and memory, especially in planning and organization to achieve a goal. Cognitive deficits are the most disabling for patients trying to lead a normal life.
Visit the Schizophrenia Research Forum, fully sponsored by the Brain & Behavior Research Foundation—a virtual community of scientists collaborating in their quest for causes, improved treatments, and better understanding of schizophrenia.
Contact: Dianne Ackerman
Brain & Behavior Research Foundation
FOR IMMEDIATE RELEASE
Contact: Dianne Ackerman
Phone: (516) 829-0091
Professor Edward R. Watkins, NARSAD Young Investigator, finds that, for the 20% of major depressive episodes that become chronic and treatment-resistant, remission is improved when Cognitive Behavioral Therapy (CBT) is...
This year, we once again honored the legacies of Gerald L. Klerman, M.D. and Daniel X. Freedman, M.D., by recognizing outstanding work of those we have supported with NARSAD Young Investigator Grants. At our dinner in...
Scientific Council Member, Bryan L. Roth, M.D., Ph.D., developed a special receptor that was added to serotonin-producing neurons in mice, enabling a powering down of these cells, which affect breathing, body temperature...